Cargando…

Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial

Detalles Bibliográficos
Autores principales: Bex, A, Mulders, P, Jewett, M, Wagstaff, J, van Thienen, JV, Blank, CU, Zequi, Stênio de C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088480/
https://www.ncbi.nlm.nih.gov/pubmed/32167723
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.03.12
_version_ 1783509545797025792
author Bex, A
Mulders, P
Jewett, M
Wagstaff, J
van Thienen, JV
Blank, CU
Zequi, Stênio de C.
author_facet Bex, A
Mulders, P
Jewett, M
Wagstaff, J
van Thienen, JV
Blank, CU
Zequi, Stênio de C.
author_sort Bex, A
collection PubMed
description
format Online
Article
Text
id pubmed-7088480
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Urologia
record_format MEDLINE/PubMed
spelling pubmed-70884802020-04-01 Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial Bex, A Mulders, P Jewett, M Wagstaff, J van Thienen, JV Blank, CU Zequi, Stênio de C. Int Braz J Urol Update in Urology Sociedade Brasileira de Urologia 2020-02-20 /pmc/articles/PMC7088480/ /pubmed/32167723 http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.03.12 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Update in Urology
Bex, A
Mulders, P
Jewett, M
Wagstaff, J
van Thienen, JV
Blank, CU
Zequi, Stênio de C.
Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
title Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
title_full Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
title_fullStr Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
title_full_unstemmed Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
title_short Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
title_sort editorial comment: comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the surtime randomized clinical trial
topic Update in Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088480/
https://www.ncbi.nlm.nih.gov/pubmed/32167723
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.03.12
work_keys_str_mv AT bexa editorialcommentcomparisonofimmediatevsdeferredcytoreductivenephrectomyinpatientswithsynchronousmetastaticrenalcellcarcinomareceivingsunitinibthesurtimerandomizedclinicaltrial
AT muldersp editorialcommentcomparisonofimmediatevsdeferredcytoreductivenephrectomyinpatientswithsynchronousmetastaticrenalcellcarcinomareceivingsunitinibthesurtimerandomizedclinicaltrial
AT jewettm editorialcommentcomparisonofimmediatevsdeferredcytoreductivenephrectomyinpatientswithsynchronousmetastaticrenalcellcarcinomareceivingsunitinibthesurtimerandomizedclinicaltrial
AT wagstaffj editorialcommentcomparisonofimmediatevsdeferredcytoreductivenephrectomyinpatientswithsynchronousmetastaticrenalcellcarcinomareceivingsunitinibthesurtimerandomizedclinicaltrial
AT vanthienenjv editorialcommentcomparisonofimmediatevsdeferredcytoreductivenephrectomyinpatientswithsynchronousmetastaticrenalcellcarcinomareceivingsunitinibthesurtimerandomizedclinicaltrial
AT blankcu editorialcommentcomparisonofimmediatevsdeferredcytoreductivenephrectomyinpatientswithsynchronousmetastaticrenalcellcarcinomareceivingsunitinibthesurtimerandomizedclinicaltrial
AT zequisteniodec editorialcommentcomparisonofimmediatevsdeferredcytoreductivenephrectomyinpatientswithsynchronousmetastaticrenalcellcarcinomareceivingsunitinibthesurtimerandomizedclinicaltrial